US & China "enhanced mutual understanding"
This article was originally published in Clinica
Trade concerns and medtech regulatory knowledge-sharing were key agenda items at a China-US meeting hosted by the Chinese State Food and Drug Administration (SFDA) on April 18-19. The China Association for Medical Devices Industry (CAMDI) praised the meeting, in Guilin, Guangxi province as having "enhanced mutual understanding" between Chinese and US regulatory authorities and business communities.
You may also be interested in...
ResMed plans to double or even triple production of intensive ventilators and sleep apnea machines this year amid rising demand by hospitals to use CPAP and BPAP machines to treat COVID-19 patients during the ventilator shortage.
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.
The economic stress on payers caused by the pandemic will cause a setback in the development of payment approaches for regenerative therapy, Blue Cross Blue Shield executive warns.